The DOI matches its Crossref record; 315 of the 315 references it cites were found in a registry or an index.
Upsides and Downsides of Reactive Oxygen Species for Cancer: The Roles of Reactive Oxygen Species in Tumorigenesis, Prevention, and Therapy
Open accessAbstract
SIGNIFICANCE: Extensive research during the last quarter century has revealed that reactive oxygen species (ROS) produced in the body, primarily by the mitochondria, play a major role in various cell-signaling pathways. Most risk factors associated with chronic diseases (e.g., cancer), such as stress, tobacco, environmental pollutants, radiation, viral infection, diet, and bacterial infection, interact with cells through the generation of ROS. RECENT ADVANCES: ROS, in turn, activate various transcription factors (e.g., nuclear factor kappa-light-chain-enhancer of activated B cells [NF-κB], activator protein-1, hypoxia-inducible factor-1α, and signal transducer and activator of transcription 3), resulting in the expression of proteins that control inflammation, cellular transformation, tumor cell survival, tumor cell proliferation and invasion, angiogenesis, and metastasis. Paradoxically, ROS also control the expression of various tumor suppressor genes (p53, Rb, and PTEN). Similarly, γ-radiation and various chemotherapeutic agents used to treat cancer mediate their effects through the production of ROS. Interestingly, ROS have also been implicated in the chemopreventive and anti-tumor action of nutraceuticals derived from fruits, vegetables, spices, and other natural products used in traditional medicine. CRITICAL ISSUES: These statements suggest both "upside" (cancer-suppressing) and "downside" (cancer-promoting) actions of the ROS. Thus, similar to tumor necrosis factor-α, inflammation, and NF-κB, ROS act as a double-edged sword. This paradox provides a great challenge for researchers whose aim is to exploit ROS stress for the development of cancer therapies. FUTURE DIRECTIONS: the various mechanisms by which ROS mediate paradoxical effects are discussed in this article. The outstanding questions and future directions raised by our current understanding are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
8 retracted
Items 201–315 of 315
Wang, X., Son, Y., Chang, Q., Sun, L., Hitron, J. A., Budhraja, A., Zhang, Z., Ke, Z., Chen, F., Luo, J., et al. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr180 · Cited by 115
Kim, H.-S., Bowen, P. E., Chen, L., Duncan, C., Ghosh, L., Sharifi, R., & Christov, K. T. (2003) · Nutrition and Cancer · doi:10.1207/s15327914nc4701_5 · Cited by 114
Brar, S. S., Kennedy, T. P., Whorton, A. R., Sturrock, A., Huecksteadt, T. P., Ghio, A. J., & Hoidal, J. R. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.3.c659 · Cited by 113
Pathi, S. S., Jutooru, I., Chadalapaka, G., Sreevalsan, S., Anand, S. K., Thatcher, G. R. J., & Safe, S. H. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0363 · Cited by 111
Хромова, Н. В., Kopnin, P., Степанова, Е. В., Agapova, L. S., & Kopnin, B. P. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.049 · Cited by 110
EGF promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and activation of MMP-2
Binker, M. G., Binker-cosen, A. A., Richards, D., Oliver, B., & Cosen-Binker, L. I. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.080 · Cited by 110
A critical role for Romo1-derived ROS in cell proliferation
Na, A. R., Chung, Y. M., Lee, S. B., Park, S. H., Lee, M.-S., & Yoo, Y. D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.098 · Cited by 110
Hussain, A. R., Ahmed, M., Ahmed, S. O., Manogaran, P. S., Platanias, L. C., Alvi, S. N., Al-Kuraya, K. S., & Shahab Uddin, M. S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.034 · Cited by 108
Wu, X., Zhu, Y. T., Yan, H., Liu, B., Li, Y., Zhou, Q., & Xu, K. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-269 · Cited by 108
Antiangiogenic Potential of Three Triterpenic Acids in Human Liver Cancer Cells
Lin, C.-C., Huang, C., Mong, M., Chan, C., & Yin, M. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf103904b · Cited by 107
Involvement of ROS in chlorogenic acid-induced apoptosis of Bcr-Abl+ CML cells
Rakshit, S., Mandal, L., Pal, B. C., Bagchi, J., Biswas, N., Chaudhuri, J., Chowdhury, A. A., Manna, A., Chaudhuri, U., Konar, A., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.08.013 · Cited by 106
Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma
Ma, Q., Cavallin, L. E., Yan, B., Zhu, S., Duran, E. M., Wang, H., Hale, L. P., Dong, C., Cesarman, E., Mesri, E. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812688106 · Cited by 105
Chemotherapy: induction of stress responses
Tiligada, E. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01272 · Cited by 103
Yang, S., Evens, A. M., Prachand, S., Singh, A. T. K., Bhalla, S., David, K. A., & Gordon, L. I. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0883 · Cited by 102
Liu, P., Chen, Y., Chen, Y., Lin, S., & Kou, Y. R. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00099.2005 · Cited by 102
Jiang, M., Liao, C.-F., & Lee, P. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4637 · Cited by 100
Luca, A. D., Sanna, F., Sallese, M., Ruggiero, C., Grossi, M., Sacchetta, P., Rossi, C., Laurenzi, V. D., Ilio, C. D., & Favaloro, B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010171107 · Cited by 99
Du, J., Sun, C., Hu, Z., Yu, Y., Zhu, Y., Zheng, D., Gu, L., & Lu, X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015940 · Cited by 97
Kim, J. S., Ahn, K. J., Kim, J., Kim, H. M., Lee, J. D., Lee, J. M., Kim, S., & Park, J. H. (2008) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-008-9188-0 · Cited by 96
Chemosensitization of Cancer by Nitric Oxide
Sullivan, R., & Graham, C. H. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784246225 · Cited by 96
Ho, B., Wu, Y., Chang, K., & Pan, T. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.869 · Cited by 95
Gibson, S. B. (2010) · Autophagy · doi:10.4161/auto.6.7.13335 · Cited by 94
Policastro, L., Molinari, B. L., Larcher, F., Blanco, P., Podhajcer, O. L., Costa, C. S., Rojas, P. A., & Durán, H. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20001 · Cited by 93
Gutin, P. H., Wilson, C. B., Kumar, A. R. V., Boldrey, E. B., Levin, V. A., Powell, M., & Enot, K. J. (1975) · Cancer · Cited by 92
Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53.
Angelo, L. S., Talpaz, M., & Kurzrock, R. (2002) · PubMed · Cited by 91
Dubois, J., Bussières, E., Richaud, P. M., Rouanet, P., Bécouarn, Y., Mathoulin‐Pélissier, S., Saint‐Aubert, B., & Ychou, M. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.01.017 · Cited by 91
Antioxidants in Cancer Therapy
Prasad, K. N., & Cole, W. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1327 · Cited by 89
METHYL-HYDRAZINE IN TREATMENT OF HODGKIN'S DISEASE AND VARIOUS FORMS OF HÆMATOSARCOMA AND LEUKÆMIA
Mathé, G., Schweisguth, O., Schneider, M., Amiel, J. L., Bérumen, L., Brulé, G., Cattan, A. R., & Schwarzenberg, L. (1963) · The Lancet · doi:10.1016/s0140-6736(63)92854-x · Cited by 88
Chatterjee, S. J., & Pandey, S. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.2.13798 · Cited by 86
Koh, E. K., Ryu, B., Jeong, D.-Y., Bang, I. S., Nam, M. H., & Chae, K. S. (2008) · International Journal of Radiation Biology · doi:10.1080/09553000802460206 · Cited by 86
Shi, D., Yu-Ru, D., Liu, S., YaDong, Z., & Lian, W. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00338-7 · Cited by 85
Park, E., Choi, K. S., & Kwon, T. K. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.10.013 · Cited by 85
Wang, H., Ma, J., Tan, Y., Wang, Z., Sheng, C., Chen, S., & Ding, J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091207 · Cited by 84
亜ヒ酸ナトリウムは,ヒト乳癌MCF‐7細胞においてROS発生,DNA酸化損傷,HO‐1とc‐Myc蛋白質,NF‐κB活性化および細胞増殖を誘導する
Ruben, R.-R., Lizbeth, L.-C., Alfonso, D. R.-P., de Andréa, & Mariano, E. C. (2009) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · Cited by 83
Yang, E. S., Choi, M. J., Kim, J. H., Choi, K. S., & Kwon, T. K. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.01.015 · Cited by 82
Pietro, C. D., Piro, S., Tabbı̀, G., Ragusa, M. A., Pietro, V. D., Zimmitti, V., Cuda, F., Anello, M., Consoli, U., Salinaro, E. T., et al. (2005) · APOPTOSIS · doi:10.1007/s10495-005-3346-1 · Cited by 82
ROS-mediated autophagy was involved in cancer cell death induced by novel copper(II) complex
Guo, W.-J., Ye, S.-S., Cao, N., Huang, J., Gao, J., & Chen, Q. (2009) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2009.08.001 · Cited by 79
Yuk, J., Shin, D., Song, K., Lim, K., Kim, K.-H., Lee, S.-H., Kim, J., Kim, J., Lee, J., Paik, T.-H., et al. (2010) · Autophagy · doi:10.4161/auto.6.1.10325 · Cited by 77
Atsumi, T., Fujisawa, S., & Tonosaki, K. (2005) · Oral Diseases · doi:10.1111/j.1601-0825.2005.01067.x · Cited by 76
Radiobiological Basis of Low-Dose Irradiation in Prevention and Therapy of Cancer
Pollycove, M. (2007) · Dose-Response · doi:10.2203/dose-response.06-112.pollycove · Cited by 75
Mammalian Peroxisomes: Metabolism of Oxygen and Reactive Oxygen Species
Singh, I. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18648.x · Cited by 74
Involvement of catalase in the apoptotic mechanism induced by apigenin in HepG2 human hepatoma cells
Valdameri, G., Trombetta-Lima, M., Worfel, P. R., Pires, A. R. A., Martinez, G. R., Noleto, G. R., Cadena, S. M. S. C., Sogayar, M. C., Winnischofer, S. M. B., & Rocha, M. E. M. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.06.009 · Cited by 73
Alajez, N. M., Shi, W., Hui, A. B., Yue, S., Ng, R., Lo, K. W., Bastianutto, C., O’Sullivan, B., Gullane, P., & Liu, F. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.85 · Cited by 70
Nguyen, G. H., Schetter, A. J., Chou, D. B., Bowman, E. D., Zhao, R., Hawkes, J. E., Mathé, E. A., Kumamoto, K., Zhao, Y., Budhu, A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1110 · Cited by 69
Wu, X., & Hua, X. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.5.4092 · Cited by 68
Ahn, J., Ambrosone, C. B., Kanetsky, P. A., Tian, C., Lehman, T. A., Kropp, S., Helmbold, I., von Fournier, D., Haase, W., Sautter-Bihl, M. L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0039 · Cited by 68
Inhibition of metastatic tumor growth by targeted delivery of antioxidant enzymes
Nishikawa, M., Hyoudou, K., Kobayashi, Y., Umeyama, Y., Takakura, Y., & Hashida, M. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.017 · Cited by 67
Das, L., & Vinayak, M. (2011) · Bioscience Reports · doi:10.1042/bsr20110043 · Cited by 67
Shanmugam, R., Kusumanchi, P., Liang Cheng, C., Crooks, P. A., Neelakantan, S., Matthews, W., Nakshatri, H., & Sweeney, C. J. (2010) · The Prostate · doi:10.1002/pros.21141 · Cited by 67
Liu, J., Du, J., Zhang, Y., Sun, W., Smith, B. J., Oberley, L. W., & Cullen, J. J. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.105 · Cited by 67
Reactive oxygen species mediate lysophosphatidic acid induced signaling in ovarian cancer cells
Saunders, J. A., Rogers, L. C., Klomsiri, C., Poole, L. B., & Daniel, L. W. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.663 · Cited by 66
Rungtabnapa, P., Nimmannit, U., Halim, H., Rojanasakul, Y., & Pithi Chanvorachote, B. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00249.2010 · Cited by 65
ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells
Chetram, M. A., Don-Salu-Hewage, A. S., & Hinton, C. V. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.074 · Cited by 64
Chung (2010) · International Journal of Oncology · doi:10.3892/ijo_00000775 · Cited by 63
Isothiocyanates inhibit proteasome activity and proliferation of multiple myeloma cells
Mi, L., Gan, N., & Chung, F. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq242 · Cited by 63
Chen, J., Da, W.-M., Zhang, D., Liu, Q., & Kang, J. (2005) · PubMed · Cited by 63
Melatonin enhances hydrogen peroxide-induced apoptosis in human promyelocytic leukaemia HL-60 cells
Bejarano, I., Espino, J., Marchena, A. M., Barriga, C., Paredes, S. D., Rodríguez, A. B., & Pariente, J. A. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0783-8 · Cited by 62
Loss of fibulin-5 binding to β1 integrins inhibits tumor growth by increasing the level of ROS
Schluterman, M. K., Chapman, S. L., Korpanty, G. J., Ozumi, K., Fukai, T., Yanagisawa, H., & Brekken, R. A. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.003707 · Cited by 62
Lim, S., Duong, H., Choi, J. E., Lee, T.-B., Kang, J., Oh, S. H., & Han, S. I. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr038 · Cited by 61
relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells
Ricca, A., Biroccio, A., Trisciuoglio, D., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2174 · Cited by 59
Toler, S. M., Noe, D. A., & Sharma, A. (2006) · Neurosurgical FOCUS · doi:10.3171/foc.2006.21.6.1 · Cited by 58
Geborek, P., Nitelius, E., Noltorp, S., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.036715 · Cited by 58
PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal
Hyoudou, K., Nishikawa, M., Kobayashi, Y. O., Umeyama, Y., Yamashita, F., & Hashida, M. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.08.004 · Cited by 56
Phase I Trial of Imexon in Patients With Advanced Malignancy
Dragovich, T., Gordon, M. S., Mendelson, D. S., Wong, L., Modiano, M., Chow, H. ‐. S., Samulitis, B. K., O'Day, S. J., Grenier, K., Hersh, E. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9672 · Cited by 56
Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo
Wang, X., Zhang, J., & Xu, T. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.10.029 · Cited by 56
A Role for Hydrogen Peroxide in the Pro‐apoptotic Effects of Photodynamic Therapy
Price, M., Terlecky, S. R., & Kessel, D. H. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2009.00589.x · Cited by 56
Kim, A. D., Kang, K. A., Zhang, R., Lim, C., Kim, H. S., Kim, D. H., Jeon, Y. J., Lee, C. H., Park, J., Chang, W. Y., et al. (2010) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2010.04.008 · Cited by 55
Genetic predictors of long‐term toxicities after radiation therapy for breast cancer
Kuptsova, N., Chang-Claude, J. C., Kropp, S., Helmbold, I., Schmezer, P., von Fournier, D., Haase, W., Sautter-Bihl, M. L., Wenz, F. K., Onel, K., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23138 · Cited by 55
Nguyen, H., & Syed, V. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.538100 · Cited by 55
PKCδ activation mediates angiogenesis via NADPH oxidase activity in PC‐3 prostate cancer cells
Kim, J., Koyanagi, T., & Mochly‐Rosen, D. (2010) · The Prostate · doi:10.1002/pros.21310 · Cited by 55
Uchikura, K., Wada, T., Hoshino, S., Nagakawa, Y., Aiko, T., Bulkley, G. B., Klein, A. S., & Sun, Z. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00314.2003 · Cited by 54
Lemjabbar‐Alaoui, H., Sidhu, S., Mengistab, A., Gallup, M., & Basbaum, C. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017489 · Cited by 53
Gapuzan, M.-E. R., Yufit, P. V., & Gilmore, T. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205333 · Cited by 53
Medan, D., Wang, L., Toledo, D., Lu, B., Stehlik, C., Jiang, B., Shi, X., & Rojanasakul, Y. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20201 · Cited by 52
Signaling pathways involved in antioxidant control of glioma cell proliferation
Martín, V., Herrera, F., García‐Santos, G., Antolín, I., Rodríguez‐Blanco, J., & Rodríguez, C. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.02.028 · Cited by 48
Lee (1992) · International Journal of Oncology · doi:10.3892/ijo_00000115 · Cited by 48
Nair, R. R., Emmons, M. F., Cress, A. E., Argilagos, R. F., Lam, K. S., Kerr, W. T., Wang, H., Dalton, W. S., & Hazlehurst, L. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0113 · Cited by 47
Pro‐inflammatory angiogenesis is mediated by p38 MAP kinase
Gangaraju, R., Kamocka, M. M., Marin, A., Suckow, M. A., Wolter, W. R., Badve, S., Sanjeevaiah, A. R., Pumiglia, K. M., Rosen, E. D., & Clauss, M. A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22404 · Cited by 46
Azad, N., Iyer, A. K. V., Wang, L., Lu, Y., Medan, D., Castranova, V., & Rojanasakul, Y. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0094oc · Cited by 46
Yu, Y., & Xiaoyan, X. (2007) · European Journal of Cancer Prevention · doi:10.1097/01.cej.0000236259.88146.a4 · Cited by 45
Yang, S., Misner, B., Chiu, R. J., & Meyskens, F. L. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm128 · Cited by 45
Shimura, K., Shimazaki, C., Taniguchi, K., Akamatsu, S., Okamoto, M., Uchida, R., Nomura, K.-I., Inaba, T., Horiike, S., Kanamura, N., et al. (2006) · International Journal of Hematology · doi:10.1532/ijh97.06110 · Cited by 43
Protective Effect of Vitamin C on Oxidative Stress: a Randomized Controlled Trial
Sasazuki, Hayashi, Nakachi, Sasaki, Tsubono, Okubo, Hayashi, & Tsugane (2008) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.78.3.121 · Cited by 41
Kang (1994) · Oncology Reports · doi:10.3892/or_00000053 · Cited by 41
Okamoto, M., Kawamata, H., Kawai, K., & Oyasu, R. (1995) · PubMed · Cited by 40
Wang, J. (2011) · Oncology Reports · doi:10.3892/or.2011.1390 · Cited by 38
Angiopoietin-1 variant, COMP-Ang1 attenuates hydrogen peroxide-induced acute lung injury
Kim, S. R., Lee, K. S., Park, S. J., Min, K. H., Lee, K. Y., Choe, Y. H., Hong, S. H., Koh, G. Y., & Lee, Y. C. (2008) · Experimental & Molecular Medicine · doi:10.3858/emm.2008.40.3.320 · Cited by 38
Sodium Selenite-Induced Apoptosis Mediated by ROS Attack in Human Osteosarcoma U2OS Cells
Chen, X., Duan, F.-D., Zhang, H., Xiong, Y., & Wang, J. (2011) · Biological Trace Element Research · doi:10.1007/s12011-011-9154-2 · Cited by 37
Yang, W., Fong, Y., Lee, C., Jin, T., Tzen, J. T. C., Li, T., & Tang, C. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23072 · Cited by 37
Good cells gone bad: the cellular origins of cancer
Wang, J. C. Y. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.01.001 · Cited by 35
Lin, K., Huang, A., Hour, T., Yang, S., Pu, Y., & Lin, C. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.05.054 · Cited by 35
Regulation of autophagy in hematological malignancies: role of reactive oxygen species
Ishdorj, G., Li, L., & Gibson, S. B. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.604752 · Cited by 35
Lenehan, P. F., Gutiérrez, P. L., Wagner, J. L., Milak, N., Fisher, G. R., & Ross, D. D. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050250 · Cited by 35
Wochna, A., Niemczyk, E., Kurono, C., Masaoka, M., Kędzior, J., Slominska, E. M., Lipiński, M., & Wakabayashi, T. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.11.005 · Cited by 34
Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancer
Maeda, S. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1141 · Cited by 34
Reactive Oxygen Species May Have Antitumor Activity in Metastatic Melanoma
Tuma, R. S. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm299 · Cited by 33
Hour, T., Huang, C., Lin, C.-C., Chen, J., Guan, J., Lee, J.-M., & Pu, Y. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200409000-00007 · Cited by 30
Yang, C., Jo, S., Csernus, B., Hyjek, E. M., Liu, Y., Chadburn, A., & Wang, Y. L. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060651 · Cited by 29
Maehata, Y., Ozawa, S., Kobayashi, K., Kato, Y., Yoshino, F., Miyamoto, C., Izukuri, K., Kubota, E., Hata, R., & Lee, M. (2010) · Free Radical Research · doi:10.3109/10715762.2010.490836 · Cited by 29
Wen, D.-S., Zhu, X., Guan, S., et al. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.06.016 · Cited by 27
Shu, D., Qing, Y., Tong, Q., He, Y., Xing, Z., Zhao, Y., Li, Y., Wei, Y., Huang, W. Q., & Wu, X. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1231 · Cited by 27
The organotelluride catalyst LAB027 prevents colon cancer growth in the mice
Coriat, R., Marut, W., Leconte, M., Ba, L., Vienne, A., Chéreau, C., Alexandre, J., Weill, B. J., Doering, M., Jacob, C., et al. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.73 · Cited by 26
Eblin, K. E., Jensen, T. J., Wnek, S. M., Buffington, S. E., Futscher, B. W., & Gandolfi, A. J. (2008) · Toxicology · doi:10.1016/j.tox.2008.10.007 · Cited by 25
Salama, S., Diaz‐Arrastia, C., Patel, D., Botting, S. K., & Hatch, S. S. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.10.080 · Cited by 23
Choudhary, S., Wang, K.-K. A., & Wang, H. R. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20708 · Cited by 23
Molecular Analysis of Genetic Instability Caused by Chronic Inflammation
Yan, B., Peng, Y., & Li, C. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-530-9_2 · Cited by 23
Concurrent use of antioxidants in cancer therapy: an update
Akbas, H. S., Timur, M., & Özben, T. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.6.931 · Cited by 20
Qin, Y., Pan, X., Tang, T., Zhou, L., & Gong, X. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.07.004 · Cited by 19
The relationship between inflammation and cancer is analogous to that between fuel and fire.
Aggarwal, B. B., & Sung, B. (2011) · PubMed · Cited by 18
Self-citationCaspase‐independent necrotic cell death induced by a radiosensitizer, 8‐nitrocaffeine
Naito, M., Hashimoto, C., Masui, S., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03216.x · Cited by 14
Garbarino, J. A., Cardile, V., Lombardo, L., Chamy, M. C., Piovano, M., & Russo, A. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2007.06.031 · Cited by 12
Plasma ascorbic acid and risk of heart disease and cancer
Burr, M., Appleby, P. N., Key, T. J., & Thorogood, M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05207-7 · Cited by 11
Horan, T. C., Zompa, M. A., Seto, C. T., Kim, K., Moore, R. G., & Lange, T. S. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9728-z · Cited by 7
Lou, J.-S., Zhou, X.-L., Weng, Q.-J., Wang, D.-D., Xia, Q., Hu, Y.-Z., He, Q., Yang, B., & Luo, P. (2010) · Bioscience, biotechnology and biochemistry · doi:10.1271/bbb.90889 · Cited by 6
(2001) · PubMed
Cited by
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Wallace, D. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3365 · Cited by 2,404
ROS and the DNA damage response in cancer
Srinivas, U. S., Tan, B. W. Q., Vellayappan, B. A., & Jeyasekharan, A. D. (2019) · Redox Biology · doi:10.1016/j.redox.2018.101084 · Cited by 2,144
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
Zhou, Z., Song, J., Nie, L., & Chen, X. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00271d · Cited by 2,098
Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals
Prasad, S., Gupta, S. C., & Tyagi, A. K. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.03.042 · Cited by 978
Self-citation
Metadata
- Authors
- Gupta, S. C., Hevia, D., Patchva, S., Park, B., Koh, W., & Aggarwal, B. B.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2012-06
- Volume
- 16
- Issue
- 11
- Pages
- 1295-1322
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W1997238548
- Cited by
- 732
- References
- 315
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.